// App-Quantinova.ai

4645 : Cell cycle specific effects and associated DNA damage of selective inhibitors of nuclear export (SINE)

Researchers

Presenter

  • Russell T. Burke

Principal Investigators

  • Joshua Marcus

  • John DeSisto

  • Yosef Landesman

  • James D. Orth

Medical Centers

  • University of Colorado, Boulder, CO.

  • Karyopharm Therapeutics, Newton, MA

Locations

  • United States

Companies

  • Karyopharm Therapeut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Fibroblastic sarcoma

  • Solid malignancies

Biomarkers

  • p53

  • Exportin 1

  • Thrombospondin-1

Drug/Treatment

  • Selinexor

  • HT-1080

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved